SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-043931
Filing Date
2019-09-09
Accepted
2019-09-09 16:13:09
Documents
4
Period of Report
2019-09-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv529087_8k.htm 8-K 25432
2 EXHIBIT 10.1 tv529087_ex10-1.htm EX-10.1 26503
3 EXHIBIT 99.1 tv529087_ex99-1.htm EX-99.1 12734
4 GRAPHIC tv529087_logo.jpg GRAPHIC 1966
  Complete submission text file 0001144204-19-043931.txt   69028
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32295 | Film No.: 191083195
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1